以上两组资料均不包含贫血、肝肾功能异常、心脑血管疾病、糖尿病、结核病及年老无法耐受手术患者。
The patients involved did not suffered from anemia, liver and renal function disfunction, heart and cerebrovascular disease, diabetes and TB.
舒普深的不良反应发生率低(3.91%)，主要为胃肠道反应，用药后随访肝肾功能均未发现明显异常。
The adverse reactions of Sulperazon was low (3.91%), mainly showed gastrointestinal reaction, the abnormal of hepatic and renal function after administration were not found.
未发现有肝、肾功能、血糖、电解质异常。
No abnormality of hepatic and renal function, blood glucose, electrolytes were found.
应用推荐